Get started
Author

Geert A. Huls

Observed names: Geert A Huls, Geert Huls, Huls, G, Huls, Geert
OpenAlex ID: A5103710199
Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals
2020 · Isabelle A. van Zeventer, Aniek O. de Graaf, et al. · Blood · 73
PDF
Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study
2023 · Jeffrey Lancet, Farhad Ravandi, et al. · Blood · 33
Flotetuzumab As Salvage Therapy for Primary Induction Failure and Early Relapse Acute Myeloid Leukemia
2020 · Ibrahim Aldoss, Geoffrey L Uy, et al. · Blood · 15
Prophylactic Ruxolitinib for Cytokine Release Syndrome (CRS) in Relapse/Refractory (R/R) AML Patients Treated with Flotetuzumab
2020 · Geoffrey L Uy, Michael P. Rettig, et al. · Blood · 9
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression pattern
2019 · Gerbrig Berger, Mylene Gerritsen, et al. · Blood Advances · 7
PDF
Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (>= 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15)
2017 · Geert A. Huls, Dana Chiţu, et al. · Blood · 6
MP0533, a CD3-Engaging Darpin Targeting CD33, CD123, and CD70 in Patients with Relapsed/Refractory AML or MDS/AML: Preliminary Results of a Phase 1/2a Study
2023 · Thomas Pabst, Mojca Jongen-Lavrencic, et al. · Blood · 5
Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia
2023 · Miranda van der Lee, Tanja van Achtenberg, et al. · Blood · 3
Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program,
2011 · Geert A Huls, Lieke H. van der Helm, et al. · Blood · 3
A Novel Prognostic Model for Patients with Acute Myeloid Leukemia in First Relapse with Improved Prognostic Accuracy
2023 · Niek G. Van Der Maas, Dimitri Breems, et al. · Blood · 1
Measurable Residual Disease Assessment in Patients with Acute Myeloid Leukemia Aged ≥60 Years Treated with a 10-Day Decitabine Schedule Versus Intensive Chemotherapy in the AML21 Study (NCT02172872)
2023 · Adriano Venditti, Michal Kicinski, et al. · Blood · 1
Metabolism-Related Features Identify the Combination Metformin Plus NAMPT Inhibitors As a Selective Treatment Strategy in Acute Myeloid Leukemia
2023 · Isabel Weinhaeuser, Diego Pereira-Martins, et al. · Blood · 1
Immune Senescence and Exhaustion Correlate with Response to Flotetuzumab, an Investigational CD123×CD3 Bispecific Dart® Molecule, in Acute Myeloid Leukemia
2020 · Jayakumar Vadakekolathu, Tung On Yau, et al. · Blood · 1
Gene Expression Profiling In Leukemic Stem Cell-Enriched AML CD34+ Cell Fraction Identifies Target Genes That Predict Prognosis In Normal Karyotype AML
2010 · Carolien M Woolthuis, Hendrik JM de Jonge, et al. · Blood · 1
Patients with Relapsed Large B-Cell Lymphoma after 12 Months Have a Similarly Poor Prognosis As Patients with a Relapse before 12 Months
2023 · Hilde T Van Der Galien, Hilde AM Kooistra, et al. · Blood
Clonal Hematopoiesis Is Common in Long-Term Survivors of Pediatric Hematopoietic Cell Transplantation, Including Umbilical Cord Blood Transplantation
2023 · Konradin F. Müskens, Maaike G.J.M. van Bergen, et al. · Blood
Richtlijn Acute promyelocytenleukemie (APL): richtlijnen voor diagnostiek en behandeling
2018 · Huls, G, Löwenberg, Bob, et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
Nieuwe ontwikkelingen voor patienten met geavanceerde systemische mastocytose
2018 · Nelemans, Johanna, Span, Lambert F.R., et al. · University of Groningen research database (University of Groningen / Centre for Information Technology)
Autologous Stem Cell Transplantation Induces a Phenotypical Shift From CMP to GMP Progenitors, Reduces Clonogenic Potential and Enhances in Vitro and In Vivo Cycling Activity Defined by 18f-FLT PET Scan.
2009 · Carolien M. Woolthuis, Ali Agool, et al. · Blood
Long-Term Expansion and Self Renewal Is Contained in the CD34+, but Not the CD34- Subfraction of Nucleophosmin Mutated Acute Myeloid Leukemia Cells.
2008 · Carolien Woolthuis, Lina Han, et al. · Blood
Distinct Gene Expression Profiling in AML in Elderly Versus Younger Patients
2008 · Henk-Marijn de Jonge, Evelina S de Bont, et al. · Blood
Works count: 23
Citation count: 159
H-index: 6
I10-index: 3
Year
Topic
Type